Aakaar Medical
NSE: AAKAAR · Personal Care
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Aakaar Medical's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Aakaar Medical Technologies Limited is an aesthetic medical company specialising in the distribution of cosmetic products and devices. The firm operates within the medical aesthetics segment, serving a professional client base of dermatologists, plastic surgeons, and aesthetic physicians.
Business Model
The company employs a business-to-business (B2B) model, supplying specialized medical aesthetic equipment and products directly to healthcare practitioners.
Growth Outlook
Growth is driven by the increasing demand for aesthetic procedures and the expansion of the professional cosmetic market in India.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent and evolving regulations governing medical devices and cosmetic products in India.
- Market Competition. The aesthetic medical sector is highly competitive, with numerous domestic and international players vying for market share.
- Technological Obsolescence. Rapid advancements in aesthetic technology may render existing product portfolios obsolete if the company fails to innovate or update its offerings.
- Economic Sensitivity. Demand for elective aesthetic procedures can be sensitive to fluctuations in disposable income and broader economic conditions.
Start your research today
Unlock AI insights, financials, peers and live data on Aakaar Medical and 5,000+ companies — free.
Peers · Personal Care
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Aakaar MedicalAAKAAR | ₹99 Cr | — | — | — | 15.4% | — | — | -20.5% |
Gillette India Ltd.GILLETTE | ₹23,116 Cr | 33.65 | 23.15 | 38.3% | 31.1% | 67.8% | 83.2% | -28.1% |
Emami Ltd.EMAMILTD | ₹17,087 Cr | 21.73 | 16.10 | 2.8% | 27.0% | 26.7% | 30.3% | -31.3% |
Honasa Consumer Ltd.HONASA | ₹15,809 Cr | 56.01 | 40.99 | 21.1% | 15.0% | 19.2% | 23.6% | +49.3% |
Bajaj Consumer Care LimitedBAJAJCON | ₹6,607 Cr | 29.76 | 22.62 | 25.8% | 23.5% | 29.7% | 36.0% | +110.6% |
Anondita Medi.ANONDITA | ₹2,085 Cr | — | — | — | 37.0% | — | — | +188.4% |
As of Mar 2026
Financials
Aakaar Medical
NSE: AAKAAR · Personal Care
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Aakaar Medical's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Aakaar Medical Technologies Limited is an aesthetic medical company specialising in the distribution of cosmetic products and devices. The firm operates within the medical aesthetics segment, serving a professional client base of dermatologists, plastic surgeons, and aesthetic physicians.
Business Model
The company employs a business-to-business (B2B) model, supplying specialized medical aesthetic equipment and products directly to healthcare practitioners.
Growth Outlook
Growth is driven by the increasing demand for aesthetic procedures and the expansion of the professional cosmetic market in India.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent and evolving regulations governing medical devices and cosmetic products in India.
- Market Competition. The aesthetic medical sector is highly competitive, with numerous domestic and international players vying for market share.
- Technological Obsolescence. Rapid advancements in aesthetic technology may render existing product portfolios obsolete if the company fails to innovate or update its offerings.
- Economic Sensitivity. Demand for elective aesthetic procedures can be sensitive to fluctuations in disposable income and broader economic conditions.
Start your research today
Unlock AI insights, financials, peers and live data on Aakaar Medical and 5,000+ companies — free.
Peers · Personal Care
As of Mar 2026